Prion diseases are a group of rare, always-fatal brain disorders caused not by a bacterium or virus but by a misfolded protein that corrupts normal proteins in the brain. They are sometimes called transmissible spongiform encephalopathies because the damage leaves the brain riddled with tiny holes, giving it a sponge-like appearance under a microscope. What makes prion diseases so unusual in medicine is their mechanism: a single protein, folded into the wrong shape, can trigger a chain reaction that no current treatment can stop. That strangeness also makes the science around prions surprisingly relevant to more common conditions.
How a Misfolded Protein Becomes an Infectious Agent
Your brain cells normally produce a protein called PrP (prion protein). In its healthy form, known as PrPC, the protein sits on the surface of neurons and appears to help with nerve maintenance and protection against toxic stress.1PubMed. The function of the cellular prion protein in health and disease Prion disease begins when this protein refolds into an abnormal shape called PrPSc. The misfolded version is rich in a structural pattern called beta-sheet, which makes it sticky, clump-prone, and extraordinarily tough to break down.2PubMed Central. Insight into the PrPC–>PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants
Once a misfolded PrPSc molecule exists, it acts like a template: it contacts a neighboring normal PrPC molecule and forces it into the same abnormal shape.3PubMed Central. Transition of the prion protein from a structured cellular form (PrPC) to the infectious scrapie agent (PrPSc) That newly converted molecule then converts another, and so on, in a self-propagating cascade. The accumulating clumps of misfolded protein damage synapses, trigger inflammation in surrounding brain cells, and eventually kill neurons, leaving behind the characteristic holes in brain tissue.4Acta Biochimica et Biophysica Sinica. Molecular mechanisms of neurodegeneration mediated by dysfunctional subcellular organelles in transmissible spongiform encephalopathies Unlike virtually every other infectious agent, prions contain no DNA or RNA. They are, as far as scientists can tell, composed entirely of protein.
The Three Routes to Prion Disease
Prion diseases in humans fall into three broad categories based on how the misfolding starts. The split matters because it shapes who gets sick, how the disease looks, and what (if anything) can be done to prevent it.
Sporadic
Roughly 85 to 90 percent of human prion disease is sporadic, meaning the misfolding appears to start spontaneously for no identifiable reason. Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common form, with a typical onset around the mid-60s.5JAMA Neurology. Characteristics of Established and Proposed Sporadic Creutzfeldt-Jakob Disease Variants A newer and even rarer sporadic type, variably protease-sensitive prionopathy (VPSPr), was first identified in 2008 and confirmed as a genuine prion disease through animal transmission studies.6PubMed. Variably protease-sensitive prionopathy Sporadic fatal insomnia rounds out the group. Because these cases arise without a clear trigger, they are essentially unpredictable at the individual level.
Genetic
About 10 to 15 percent of cases stem from inherited mutations in the gene that encodes the prion protein, called PRNP. These mutations make the protein more prone to misfold on its own. Genetic prion diseases include familial CJD, Gerstmann-Sträussler-Scheinker disease, and fatal familial insomnia, each linked to different specific mutations.7PubMed Central. Genetic PrP Prion Diseases A person who carries one of these mutations has a high lifetime risk of developing the disease, and there is a 50 percent chance of passing the mutation to each child. Genetic testing can identify carriers, but given that no preventive treatment exists, the decision to test is deeply personal.
Acquired
A small percentage of cases result from actual exposure to misfolded prions from an outside source. The most historically significant example is kuru, a disease once epidemic among the Fore people of Papua New Guinea, transmitted through the ritualistic consumption of deceased relatives’ brains.8PubMed Central. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice When the practice ended in the late 1950s, kuru cases gradually declined, though some appeared decades later because of the extraordinarily long incubation periods prion diseases can have. Iatrogenic CJD is another acquired form, caused by medical procedures such as contaminated surgical instruments, corneal transplants, or growth hormone extracted from cadaver pituitary glands before recombinant versions became standard. Variant CJD (vCJD), linked to eating beef contaminated with bovine spongiform encephalopathy (BSE or “mad cow disease”) prions, caused a cluster of cases in the United Kingdom starting in the mid-1990s. Genetic variation at a specific spot on the PRNP gene, codon 129, strongly influences who is susceptible to vCJD, with additional nearby genetic variants also affecting risk.9PubMed Central. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study
What Symptoms Look Like and How Quickly They Progress
Prion diseases are progressive and invariably fatal, but the specific symptoms and pace vary depending on the type and subtype. In sporadic CJD, the most common presentation begins with rapidly worsening cognitive decline: memory loss, confusion, and problems with judgment that can look at first like an aggressive dementia. Within weeks to months, patients often develop involuntary muscle jerks (myoclonus), difficulty with coordination and walking, and visual disturbances. Speech deteriorates. In the later stages, many patients enter a state called akinetic mutism, where they are awake but unresponsive and unable to move or speak voluntarily.
A ten-year review of sCJD cases in the United Kingdom found that cognitive impairment and myoclonus were present at high rates regardless of the patient’s age. However, patients over 80 were more likely to show stiffness and involuntary muscle contractions in the limbs and less likely to present with psychiatric symptoms or balance problems compared with younger patients.10Age and Ageing. Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance This age-related variation in presentation is one reason sCJD can be mistaken for other conditions in elderly patients.
Variant CJD tends to strike younger individuals and starts differently, often with psychiatric symptoms such as depression, anxiety, and personality changes months before the neurological decline becomes obvious. Fatal familial insomnia, as the name suggests, primarily attacks the brain’s sleep centers, producing relentless insomnia, panic attacks, weight loss, and autonomic dysfunction before progressing to full dementia. Survival across prion diseases ranges widely: most sCJD patients die within a year of symptom onset, while some genetic forms can progress over two or more years.
How Prion Disease Is Diagnosed
Diagnosing prion disease is tricky because the early symptoms overlap with many other brain conditions, and a definitive diagnosis has historically required examining brain tissue after death. But the diagnostic toolkit has improved considerably.
Brain MRI has become one of the most useful early tools. Diffusion-weighted imaging (DWI) can reveal distinctive patterns of restricted diffusion in the cortex and deep brain structures that are highly suggestive of CJD. In some cases, MRI detects these patterns even when other tests are negative, making it a first-line investigation when prion disease is suspected.11PubMed Central. Probable Creutzfeldt-Jakob Disease With Negative Cerebrospinal Fluid (CSF) 14-3-3 Protein: Diagnostic Value of Diffusion-Weighted MRI
An older spinal fluid test, the 14-3-3 protein assay, has been widely used as a marker of rapid neuronal destruction. An evidence-based guideline found its sensitivity to be about 92 percent and specificity around 80 percent for sporadic CJD.12PubMed Central. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease The 80 percent specificity is the problem: it means roughly one in five positive results comes from someone who does not have CJD, since other causes of rapid brain injury can also elevate 14-3-3 protein. It remains useful but has been largely supplemented by a newer test.
That newer test, called RT-QuIC (real-time quaking-induced conversion), works by essentially mimicking what prions do. A sample of spinal fluid is mixed with normal prion protein in a test tube. If misfolded prions are present in the sample, they seed a chain reaction that can be detected by fluorescence. Studies report sensitivity above 90 percent and specificity close to 100 percent, a significant improvement over the 14-3-3 assay.13PubMed Central. RT-QuIC: a new test for sporadic CJD 14PubMed. Diagnosis of prion diseases by RT-QuIC results in improved surveillance RT-QuIC has become a central part of prion disease surveillance in multiple countries. The combination of a characteristic MRI pattern and a positive RT-QuIC result now allows clinicians to make a diagnosis of probable prion disease during a patient’s lifetime with considerable confidence.
Treatment and the Research Pipeline
There is no approved treatment that can slow, halt, or reverse any human prion disease. Current medical care is palliative: managing pain, agitation, involuntary movements, and keeping patients comfortable. That blunt reality makes any research progress noteworthy, and the last several years have produced some genuinely promising results in the laboratory.
The most advanced experimental strategy targets the problem at its source by reducing the brain’s production of normal prion protein. If you lower the amount of PrPC available to be converted, the chain reaction slows or stalls. Antisense oligonucleotides (ASOs) are short, synthetic strands of modified DNA that bind to the messenger RNA for PrP and flag it for destruction before it can be translated into protein. In mice infected with prions, ASO treatment given before symptoms appeared roughly doubled survival time compared with untreated animals.15PubMed Central. Antisense oligonucleotides extend survival of prion-infected mice When treatment was delayed until the disease was already progressing, survival still increased by more than half. Follow-up studies with refined ASOs replicated and even improved on those results, with some treated animals surviving more than twice as long as controls.16Nucleic Acids Research. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
These results are striking by the standards of a disease that has resisted every previous intervention, but they come with important caveats. The mice were not cured; the disease eventually progressed. Delivering ASOs to the human brain requires repeated spinal injections, which are invasive and carry their own risks. A clinical trial in humans is underway, but results are still years from providing definitive answers. Other genetic approaches in earlier stages of development, including RNA interference and CRISPR-based gene editing, aim to achieve the same goal of reducing PrP production, potentially with more durable or even permanent effects.17PubMed. Current genetic approaches for the treatment of prion diseases Immunotherapy, small-molecule drugs, and stem cell therapy are also under investigation, though none has advanced as far as the ASO approach.18PubMed Central. New implications for prion diseases therapy and prophylaxis
Prion Diseases in Animals and What They Mean for Humans
The most widely known animal prion disease is BSE in cattle, which caused a major food-safety crisis in the 1990s when it became clear that it could cross the species barrier and cause vCJD in humans. Strict feed bans and slaughter protocols have made new BSE cases rare in most countries, and vCJD cases have dropped to near zero as a result.
The animal prion disease that currently worries wildlife biologists and public health officials is chronic wasting disease (CWD), which affects deer, elk, moose, and reindeer. CWD has been spreading steadily across North America and has been found in Scandinavia and South Korea. Unlike BSE, CWD passes directly between animals, aided by the fact that infected animals shed prions in saliva, urine, and feces, and that prions can persist in soil for years.19PubMed Central. Occurrence, transmission, and zoonotic potential of chronic wasting disease The risk to humans is currently considered low based on laboratory and epidemiological evidence, but researchers are cautious about declaring it zero. Multiple strains of CWD exist, and prion strains can evolve during passage through different species, so the possibility that a variant could emerge with greater ability to infect humans cannot be definitively ruled out.20PubMed Central. Chronic Wasting Disease in Cervids: Implications for Prion Transmission to Humans and Other Animal Species Hunters in affected areas are generally advised to have harvested animals tested and to avoid consuming meat from animals that test positive.
Why Prions Are So Hard to Destroy
One of the most unsettling properties of misfolded prions is their resistance to methods that reliably kill every other infectious agent. Standard hospital sterilization, including autoclaving at high temperature and pressure, does not fully eliminate prion infectivity. A study testing recommended decontamination protocols on surgical steel found that standard methods reduced the amount of infectious human-derived prions by less than a thousandfold, a level considered inadequate for complete safety.21PubMed. Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain Separate research has confirmed that even atypical forms of animal prion disease survive recommended autoclave procedures.22PubMed. Incomplete inactivation of atypical scrapie following recommended autoclave decontamination procedures
This extreme durability is why hospitals that perform neurosurgery or other procedures on a patient later diagnosed with prion disease typically quarantine or destroy the instruments used rather than attempting to re-sterilize them. Disposable instruments are increasingly used for high-risk procedures such as brain biopsies in patients with suspected prion disease. The problem of environmental contamination is also relevant: prions bound to soil particles remain infectious, which helps explain the persistence and spread of CWD in wild deer populations.
Blood Supply Safety
The discovery that vCJD could be transmitted through blood transfusion prompted sweeping changes to blood-donation policies in many countries. People who lived in the United Kingdom during the height of the BSE epidemic are still barred from donating blood in several nations. Research in animal models has shown that removing white blood cells from donated blood (a process called leucodepletion) significantly reduces the risk of transfusion-transmitted prion disease, though it does not eliminate it entirely.23PLOS Pathogens. Preclinical transmission of prions by blood transfusion is influenced by donor genotype and route of infection Leucodepletion has been adopted as standard practice for all donated blood in the UK and several other countries, a precaution that also benefits patients for other reasons unrelated to prions. There is still no practical blood test to screen donors for prion infection during the long, silent incubation period, which remains a gap in public health defenses.
Prion-Like Behavior in Alzheimer’s and Parkinson’s Disease
One of the most consequential developments in neuroscience over the past two decades is the recognition that the proteins involved in far more common brain diseases behave in strikingly prion-like ways. In Alzheimer’s disease, both amyloid-beta and tau proteins form misfolded aggregates that spread through the brain in a predictable pattern, seeding new misfolding in previously healthy regions.24PubMed. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein In Parkinson’s disease, alpha-synuclein does the same thing. These proteins share key biochemical and physical features with PrPSc, including the ability to convert normal versions of themselves into the misfolded form and to propagate pathology from cell to cell.25PubMed Central. Prion-like mechanisms in neurodegenerative diseases
To be clear, Alzheimer’s and Parkinson’s diseases are not contagious in the way that classic prion diseases can be. Nobody catches Alzheimer’s from a blood transfusion or a contaminated surgical instrument under normal circumstances. The “prion-like” label refers to the molecular mechanism of spread within a single brain, not transmission between people. But the parallel has reshaped how researchers think about these diseases and, more practically, how they design drugs. If slowing or blocking the misfolding cascade works in true prion disease (as the ASO experiments suggest it might), similar strategies could in theory apply to the misfolded proteins behind far more common forms of neurodegeneration. This conceptual bridge is one reason prion research, despite the rarity of prion disease itself, attracts attention and funding well beyond what its case numbers alone would justify.
What the Normal Prion Protein Actually Does
Given how dangerous its misfolded form is, you might wonder why the brain makes prion protein at all. Studies in animals engineered to lack the gene for PrP have shown that the protein plays a role in maintaining the insulation (myelin) around peripheral nerves and in protecting neurons from various forms of toxic stress.1PubMed. The function of the cellular prion protein in health and disease Animals without PrP can survive, but they show subtle deficits in nerve function and may be more vulnerable to certain injuries. The protein also appears to be involved in copper metabolism and cell signaling, though the full picture of its normal duties remains incomplete. The fact that PrPC is abundantly expressed on nerve cells throughout the brain is precisely what makes prion disease so devastating once misfolding begins: there is an enormous supply of raw material for the chain reaction to exploit. It is a case where a protein doing quiet, useful work becomes, through a change in shape, the instrument of the brain’s destruction.